Counselors in Leverett, MA Accepting Medicare

6 Counselors found. Showing 1 - 6

Mr. Charles Genre, LMHC, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 33 Lead Mine Rd, Leverett, MA 01054 Phone: 413-200-9291

Ms. Dale R Schwarz, LMHC LICENSED MENTAL Counselor Medicare: Not Enrolled in Medicare Practice Location: 13 Montague Rd, Leverett, MA 01054 Phone: 413-548-8177

Jennifer Cori Chandler Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 74 Long Hill Rd, Leverett, MA 01054 Phone: 941-626-7758

Nancy Simons, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 54 Shutesbury Rd, Leverett, MA 01054 Phone: 413-549-4854    Fax: 413-549-4854

Kimberly Ann Schildbach, M.ED. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 271 Shutesbury Rd, Leverett, MA 01054 Phone: 413-549-8152

Evan Vandy Bollinger, M.ED., LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 53 Juggler Meadow Rd, Leverett, MA 01054 Phone: 413-548-3970

News Archive

More standardized geriatric training needed across all medical specialties

The changing medical needs of the growing 65-and-over population in the United States are not being met by current medical education, University of Cincinnati (UC) researchers warn.

Researchers find how microtubules, motor proteins assemble into macroscopic networks

What bones are to bodies, the cytoskeleton is to cells. The cytoskeleton maintains cellular structure, builds appendages like flagella and, together with motor proteins, powers cellular movement, transport, and division. Microtubules are a critical component of the cytoskeleton, vital for cell division and, because of that, an excellent target for chemotherapy drugs.

New study identifies recurrent wound botulism among injection drug users

Botulism is a rare disease and recurrent botulism even more rare. However, in California, recurrent wound botulism among injection drug users has been on the rise and makes up three-quarters of reported cases in the United States.

Research provides insights into the ability of FL118 to overcome treatment resistance

The latest research from the team that discovered the novel anticancer agent FL118 highlights distinctive characteristics of this small-molecule compound and provides insights into its ability to overcome the persistent problem of treatment resistance. In findings reported in Molecular Cancer, Fengzhi Li, PhD, of Roswell Park Cancer Institute, and colleagues provide new evidence that FL118 may be more effective than two structurally similar injectable drugs and, additionally, may be effective as an oral agent.

Read more Medical News

› Verified 8 days ago